Template talk:Stimulants
I'm not that proficient in Wiki to do that. but can anyone add the [hifrf] link to this template? It is to big and gets too much space. Samuel Sol (talk) 13:41, 21 December 2007 (UTC)[reply]__DTELLIPSISBUTTON__{"threadItem":{"timestamp":"2007-12-21T13:41:00.000Z","author":"Samuel Sol","type":"comment","level":1,"id":"c-Samuel_Sol-2007-12-21T13:41:00.000Z-Adding_the_[hide]_link","replies":[]}}-->
I added the collapsed state, hopefully, this will work better for you. See:Template:Navbox for more info. I also ran disambig cleaner and am currently in the process of updating the abbreviations. It's a long list, so I'm still working on it.
Funandtrvl (talk) 13:19, 7 October 2008 (UTC). Also, updated abbreviations by checking the references to each main page, since it's easier to read by the shorter names, than by the long chemical names. Could not find the abbreviations for a few on the list. If anyone knows what they are, please add to template for us. Thanks!Funandtrvl (talk) 13:37, 7 October 2008 (UTC)[reply]__DTELLIPSISBUTTON__{"threadItem":{"timestamp":"2008-10-07T13:19:00.000Z","author":"Funandtrvl","type":"comment","level":1,"id":"c-Funandtrvl-2008-10-07T13:19:00.000Z-Added_collapsed_state","replies":[]}}-->
Used WikiCleaner to pipe the correct, current pages to several links. Please check if the auto-cleaner added the right links for Carphedon and Methylone, thanks!
Funandtrvl (talk) 04:19, 14 October 2008 (UTC)[reply]__DTELLIPSISBUTTON__{"threadItem":{"timestamp":"2008-10-14T04:19:00.000Z","author":"Funandtrvl","type":"comment","level":1,"id":"c-Funandtrvl-2008-10-14T04:19:00.000Z-Added_collapsed_state","replies":[]}}-->
Should we only add relevant substances to this list? For example, see phenethylamine class compounds: full of links to irrelevant, rare substances that IMHO should not be listed here. Also, is adding things like Venlafaxine etc. neccessary? Come on, it's about stimulants... Sorry for crappy English. --Harbinary (talk) 20:26, 17 October 2009 (UTC)[reply]__DTELLIPSISBUTTON__{"threadItem":{"timestamp":"2009-10-17T20:26:00.000Z","author":"Harbinary","type":"comment","level":1,"id":"c-Harbinary-2009-10-17T20:26:00.000Z-Template_cleanup","replies":[]}}-->
Xamoterol is listed as a phenethylamine. Xamoterol is an adrenergic agent, not a CNS stimulant per se, and is not in the phenethylamine chemical class. 24.113.109.228 (talk) 18:23, 5 September 2012 (UTC)[reply]__DTELLIPSISBUTTON__{"threadItem":{"timestamp":"2012-09-05T18:23:00.000Z","author":"24.113.109.228","type":"comment","level":1,"id":"c-24.113.109.228-2012-09-05T18:23:00.000Z-Xamoterol_removed","replies":[]}}-->
The "Others" section of this template has become a dumping ground for several phenethylamine-class stimulants. While the proper classification of some agents may be questionable (agents like Trazium have a PEA backbone, but a complex structure and an atypical nitrogenation pattern), I have moved several of the most obvious PEA-backboned agents to the more appropriate subcategory "phenethylamine":
2-Amino-1,2-dihydronaphthalene
2-Aminoindane
2-Aminotetralin
2-Phenyl-3,6-dimethylmorpholine
3-Benzhydrylmorpholine
5-(2-Aminopropyl)indole
5-IAI
AL-1095
Camfetamine
Cilobamine
Cypenamine
Fencamfamine
Feprosidnine
G-130
Mesocarb
Phthalimidopropiophenone
24.113.109.228 (talk) 18:56, 5 September 2012 (UTC) RT[reply]__DTELLIPSISBUTTON__{"threadItem":{"timestamp":"2012-09-05T18:56:00.000Z","author":"24.113.109.228","type":"comment","level":1,"id":"c-24.113.109.228-2012-09-05T18:56:00.000Z-Move_of_several_agents","replies":[]}}-->
This section REALLY needs to be split up. There are many diphenyl ethylamines (pipradrol and derivatives) for example, that should be in their own section since BOTH aromatics are a requirement. Often, totally unrelated drugs are ended up in the PEA section.
Can I add a diphenylethylamine section, as a trial? — Preceding unsigned comment added by 213.106.56.145 (talk) 10:22, 6 October 2014 (UTC)[reply]__DTELLIPSISBUTTON__{"threadItem":{"timestamp":"2014-10-06T10:22:00.000Z","author":"213.106.56.145","type":"comment","level":1,"id":"c-213.106.56.145-2014-10-06T10:22:00.000Z-Phenylethylamines","replies":["c-Erik.Bjareholt-2015-10-14T22:20:00.000Z-213.106.56.145-2014-10-06T10:22:00.000Z"]}}-->
- Be bold! --Erik.Bjareholt (talk) 22:20, 14 October 2015 (UTC)[reply]__DTELLIPSISBUTTON__{"threadItem":{"timestamp":"2015-10-14T22:20:00.000Z","author":"Erik.Bjareholt","type":"comment","level":2,"id":"c-Erik.Bjareholt-2015-10-14T22:20:00.000Z-213.106.56.145-2014-10-06T10:22:00.000Z","replies":[]}}-->
The template is using them inconsistently, in the interest of brevity I've reduced them to the shorthand (which is the most used name afaik). If you think they should all be changed to their long forms, please do so. I just want us to be consistent. Erik.Bjareholt (talk) 22:17, 14 October 2015 (UTC)[reply]__DTELLIPSISBUTTON__{"threadItem":{"timestamp":"2015-10-14T22:17:00.000Z","author":"Erik.Bjareholt","type":"comment","level":1,"id":"c-Erik.Bjareholt-2015-10-14T22:17:00.000Z-X-Flouro(meth)amphetamine_vs_X-F(M)A","replies":[]}}-->
- Please, when you change the link and users get redirected to the original page.. you new link won;t be highlighted (bold, so you know, you are on that page). Do it like this { {MLNFP |MyLongNameForPage}} .
|
|